Literature DB >> 6972789

Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro.

K E Mercola, M J Cline, D W Golde.   

Abstract

In order to investigate the effect of human growth hormone on T lymphocytes, we utilized a clonogenic assay for mitogen-responsive human peripheral blood T lymphocytes. Lymphocytes were purified by density gradient centrifugation and incubated in the presence of phytohemagglutinin using a two-layer agar technique for CFU- T-lymphocyte culture. Nanogram concentrations of human growth hormone, ovine prolactin, human chorionic somatomammotropin, or growth hormone fragment were added to cell cultures. Growth hormone potentiated normal T-cell colony formation in a species-specific manner. Cells from a homogeneous T-lymphoblast line derived from a patient with a T-cell variant of hairy cell leukemia also showed augmentation of colony growth in the presence of human growth hormone. These studies provide evidence for a direct effect of growth hormone on normal and some neoplastic human T cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972789

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Immunoreactive growth hormone production by human lymphocyte cell lines.

Authors:  T L Kao; S C Supowit; E A Thompson; W J Meyer
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

2.  Phenotypic and functional abnormalities of T lymphocytes in pathological hyperprolactinemia.

Authors:  R Gerli; C Riccardi; I Nicoletti; S Orlandi; C Cernetti; F Spinozzi; P Rambotti
Journal:  J Clin Immunol       Date:  1987-11       Impact factor: 8.317

3.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

4.  Modulation of lymphoproliferation by human growth hormone.

Authors:  W Kiess; H Holtmann; O Butenandt; R Eife
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

5.  Assessment of immune function after short-term administration of recombinant human growth hormone in healthy young males.

Authors:  S B Ramos; E W Brenu; R Christy; B Gray; L McNaughton; L Tajouri; M Van Driel; S M Marshall-Gradisnik
Journal:  Eur J Appl Physiol       Date:  2010-12-08       Impact factor: 3.078

6.  Wilms tumour in a patient with growth hormone replacement therapy.

Authors:  T Momoi; C Yamanaka; T Yorifuji; H Sasaki; M Kaji; Y Akiyama; Y Inomata; K Tanaka; H Mikawa
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

7.  Growth hormone alters lymphocyte sub-populations and antibody production in dwarf rats in vivo.

Authors:  A Schurmann; G S Spencer; C J Berry
Journal:  Experientia       Date:  1995-08-16

Review 8.  Growth hormone therapy and leukaemia.

Authors:  N Stahnke; H J Zeisel
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

9.  Lack of mitogenic effects of growth hormone on human leukemic lymphoblasts.

Authors:  J Blatt; S Wenger; S Stitely; P A Lee
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

10.  Immunological studies in patients with isolated growth hormone deficiency.

Authors:  S Gupta; S M Fikrig; M S Noval
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.